Ann: $15m raised to fund Well Test & Cabora Bassa Operations, page-104

First 104 Last

Share
Profile

Follow
Roch2077

10,189 Posts.

1986

27/12/23

13:42

Post #: 71627946
Share

Originally posted by Callsign30: ↑

Stepping back from the minutiae of the CR and looking at a more macro level:

Now we know why the SP collapsed on the MK2 ST1 discovery announcement.

PAC knew beforehand, with a shadow of a doubt, that IVZ would be conducting a CR immediately after the MK2 ST1 announcement so they sold enough shares to scare retail investors and depress the price ensuring they would be able to shortly buy back via the CR placement with free options attached, at a bargain basement price.

13 cents is outrageous!!

I am sure SM thought the CR placement would be around 25 cents, but his hand was forced.

Im not saying SM was part of this manipulation by PAC, because there was no doubt he was as confused by the SP dropping as everyone else. But he lacks the financial savvy to protect shareholders from these dirty tactics.

He is hopeless in this regard and needs to fix this weakness asap because IT WILL HAPPEN AGAIN.

The CR should have been done before the discovery announcement which would have prevented the SP drop on the MK2 ST1 announcement and the subsequent manipulation that occurred.

Much better to have a CR priced in before the discovery announcement. And for the chorus of inevitable 'no-one would support another CR before a discovery': you are 100% wrong there would have been enough support to get IVZ the funds it needed to flow test, another drill and for the 3D instead of this nonsense we now have of just being able to 'prepare' for the 3D.

What does 'prepare' for 3D even mean ???

Once the placement is finalized the manipulation will start again and the SP will rise sharply before PAC cash out their head shares at a nice profit and keep their free options.

Watch the volume traded as the SP starts to rise, it won't be significant volume, just enough to keep pushing the SP back up to around 20 cents before they sell out to unsuspecting retailers who think we are on our way north of ... checks my notes ... $2.40

Mr $2.40 plays a minor but important part in this nefarious scheme and his ramping will become unbearable as the SP starts to recover back to 20 cents.

SM needs to get a battle hardened CFO and engage EH from here on and protect ALL the shareholders going forward. His blind spot is hurting genuine investors.

Expand

lol yeh go to a 300 million market cap and then sold off because they are not about to farm in by April a multi billion dollar investment selling a piece of the company. Still going towards a 2-3 billlion dollar valuation. Goes back up either way

Last edited by Roch2077: 27/12/23

IVZ Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

FFM

Firefly positioned for copper growth in Canada ahead of resource update

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 915 more messages in this thread...

First 104 Last

Add IVZ (ASX) to my watchlist

(20min delay)
Last 7.4¢		Change -0.001(1.33%)		Mkt cap ! $112.2M

Open	High	Low	Value	Volume
7.4¢	7.6¢	7.2¢	$62.75K	846.7K

Buyers (Bids)

No.	Vol.	Price($)
2	119539	7.4¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	50000	1

View Market Depth

No.	Vol.	Price($)
2	119539	0.074
1	100000	0.073
1	13888	0.072
3	89050	0.071
4	383942	0.070

Price($)	Vol.	No.
0.075	50000	1
0.077	110600	2
0.078	115267	1
0.080	94368	4
0.081	14336	1

Last trade - 16.10pm 03/10/2024 (20 minute delay)

IVZ (ASX) Chart

Ann: $15m raised to fund Well Test & Cabora Bassa Operations, page-104

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Firefly positioned for copper growth in Canada ahead of resource update

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: $15m raised to fund Well Test & Cabora Bassa Operations, page-104

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Firefly positioned for copper growth in Canada ahead of resource update

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News